Search

Meeting Coverage:

American Glaucoma Society

AGS: 2025

The New HORIZON

Ticiana De Francesco, MD

Show Description +

Ticiana De Francesco, MD, recaps her presentation from the American Glaucoma Society annual meeting on findings from the HORIZON study, comparing eyes that underwent phacoemulsification and Hydrus Microstent (Alcon) implantation with eyes that underwent standalone phacoemulsification. She reviews data that shows statistically significant IOP lowering outcomes for patients who underwent the combination procedure.

Posted: 2/19/2025

Keywords:

Glaucoma

•

AGS

Up Next

SpyGlass Drug-Eluting Pads

SpyGlass Drug-Eluting Pads

Jason Bacharach, MD

Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial

Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial

Eileen C. Bowden, MD

Glaucoma Computerized Adaptive Test

Glaucoma Computerized Adaptive Test

Mona Kaleem, MD

Cost-Effectiveness of Current Approaches to Glaucoma Treatment

Cost-Effectiveness of Current Approaches to Glaucoma Treatment

Lama Al-Aswad, MD, MPH

AI Model to Set Target IOP

AI Model to Set Target IOP

Jithin Yohannan, MD, MPH

The Dark Side of Glaucoma Care

The Dark Side of Glaucoma Care

Kaweh Mansouri, MD, MPH

What Glaucoma Physicians Should Know About OCT

What Glaucoma Physicians Should Know About OCT

Joel S. Schuman, MD, FACS

Advances in Glaucoma Imaging: Ultrasound and OCT Elastography

Advances in Glaucoma Imaging: Ultrasound and OCT Elastography

Arthur J. Sit, MD

The New HORIZON

The New HORIZON

Ticiana De Francesco, MD

Back to All Videos

The New HORIZON

Ticiana De Francesco, MD

Ticiana De Francesco, MD, recaps her presentation from the American Glaucoma Society annual meeting on findings from the HORIZON study, comparing eyes that underwent phacoemulsification and Hydrus Microstent (Alcon) implantation with eyes that underwent standalone phacoemulsification. She reviews data that shows statistically significant IOP lowering outcomes for patients who underwent the combination procedure.

Posted: 2/19/2025

Keywords:

Glaucoma

•

AGS

Please log in to leave a comment.

More From AGS: 2025 Coverage

SpyGlass Drug-Eluting Pads

SpyGlass Drug-Eluting Pads

Jason Bacharach, MD

Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial

Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial

Eileen C. Bowden, MD

Glaucoma Computerized Adaptive Test

Glaucoma Computerized Adaptive Test

Mona Kaleem, MD

Cost-Effectiveness of Current Approaches to Glaucoma Treatment

Cost-Effectiveness of Current Approaches to Glaucoma Treatment

Lama Al-Aswad, MD, MPH

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AGS: 2025.